Alcanza Expands Reach into Puerto Rico with Acquisition of FDI Clinical Research

Alcanza Clinical Research, a mission-focused investigator site network, announces the acquisition of FDI Clinical Research, a multi-specialty research organization based in San Juan, Puerto Rico, with an additional site in the west coast city of Mayagüez. Operating in Puerto Rico since 2002, FDI specializes in Phase I-IV trials across endocrine and metabolic conditions, immunology, hepatology, infectious diseases, oncology, respiratory, and rheumatology. The headquarters site features a Phase I unit and the ability to run multiple study types, including first-in-human clinical pharmacology studies.

Read the full article: Alcanza Expands Reach into Puerto Rico with Acquisition of FDI Clinical Research //

Source: https://www.prnewswire.com/news-releases/alcanza-expands-reach-into-puerto-rico-with-acquisition-of-fdi-clinical-research-302123282.html

Leave a Comment

Your email address will not be published.

Scroll to Top